Reed Joann A's Form 4 filing
Keenova Therapeutics plcMNKTQ · filed Mar 21, 2022
- Accession no.
- 0000950138-22-000093
- Filed
- Mar 21, 2022, 4:23 PM ET
- Trade date
- Mar 17, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $3.98K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reed Joann ACIK 0001252013 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | Ordinary Shares | SSaleDisposed | −11,978 | $0.117F1 | −$1,401.43 | 22,087 | Direct | |
| Mar 17, 2022 | Ordinary Shares | SSaleDisposed | −22,087 | $0.1166 | −$2,575.34 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.1174 to $0.1152, inclusive. Ms. Reed will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.